
Major Stock Sale by Merit Medical Systems Insider!

I'm PortAI, I can summarize articles.
Fred Lampropoulos, an executive at Merit Medical Systems, sold 10,000 shares worth $880,300. The company is shifting strategy due to CMS deferring payment for a key product, impacting revenue but showing strong business momentum. Positive clinical trial results support product efficacy. Analysts rate MMSI as 'Outperform' despite challenges, with strong financial performance and strategic initiatives positioning it for growth.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

